Dermatol Ther (Heidelb) 2014;4:7181
Yin H, Li M, Tian G, Ma Y, Ning C, Yan Z, Wu J, Ge Q, Sui X, Liu S, Zheng J, Guo W, Guo Q
It's very, very exciting
If youre not comfortable with needles, we also offer a needle-free alternative : sublingual compounded semaglutide (dissolved under the tongue)
We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity
78% of our survey respondents anticipate that these medications will redefine the healthcare landscape within the next five years